SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008190
Filing Date
2021-04-07
Accepted
2021-04-07 15:11:50
Documents
60
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1206515
2 ex21-1.htm EX-21.1 3839
3 ex23-1.htm EX-23.1 2392
4 ex31-1.htm EX-31.1 19621
5 ex32-1.htm EX-32.1 5133
6 form10k_001.jpg GRAPHIC 3602
  Complete submission text file 0001493152-21-008190.txt   5044421

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atrx-20201231.xsd EX-101.SCH 38634
8 XBRL CALCULATION FILE atrx-20201231_cal.xml EX-101.CAL 44855
9 XBRL DEFINITION FILE atrx-20201231_def.xml EX-101.DEF 178537
10 XBRL LABEL FILE atrx-20201231_lab.xml EX-101.LAB 340157
11 XBRL PRESENTATION FILE atrx-20201231_pre.xml EX-101.PRE 262027
12 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 640300
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-13789 | Film No.: 21811897
SIC: 2834 Pharmaceutical Preparations